IL326329A - Ripretinib for treating gastrointestinal stromal tumors - Google Patents
Ripretinib for treating gastrointestinal stromal tumorsInfo
- Publication number
- IL326329A IL326329A IL326329A IL32632926A IL326329A IL 326329 A IL326329 A IL 326329A IL 326329 A IL326329 A IL 326329A IL 32632926 A IL32632926 A IL 32632926A IL 326329 A IL326329 A IL 326329A
- Authority
- IL
- Israel
- Prior art keywords
- kda
- polymer
- ripretinib
- patient
- molecular weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962885797P | 2019-08-12 | 2019-08-12 | |
| US201962904198P | 2019-09-23 | 2019-09-23 | |
| US201962926281P | 2019-10-25 | 2019-10-25 | |
| US201962936018P | 2019-11-15 | 2019-11-15 | |
| US202062968927P | 2020-01-31 | 2020-01-31 | |
| US202062968945P | 2020-01-31 | 2020-01-31 | |
| US202063023921P | 2020-05-13 | 2020-05-13 | |
| US202063023936P | 2020-05-13 | 2020-05-13 | |
| PCT/US2020/045876 WO2021030405A1 (en) | 2019-08-12 | 2020-08-12 | Ripretinib for treating gastrointestinal stromal tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326329A true IL326329A (en) | 2026-04-01 |
Family
ID=74566909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326329A IL326329A (en) | 2019-08-12 | 2020-08-12 | Ripretinib for treating gastrointestinal stromal tumors |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7818502B2 (cg-RX-API-DMAC10.html) |
| IL (1) | IL326329A (cg-RX-API-DMAC10.html) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019025346A2 (pt) * | 2017-05-30 | 2020-06-30 | Deciphera Pharmaceuticals, Inc. | uso de 1-[4-bromo-5-[1-etil-7-(metilamino)-2-oxo-1,2-dihidro-1,6-naftiridin-3-il]-2-fluorofenil]-3-fenilureia e análogos para o tratamento de cânceres associados a anormalidades genéticas no receptor alfa do fator de crescimento derivado de plaquetas |
-
2020
- 2020-08-12 JP JP2022508506A patent/JP7818502B2/ja active Active
- 2020-08-12 IL IL326329A patent/IL326329A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7818502B2 (ja) | 2026-02-20 |
| JP2022544234A (ja) | 2022-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3066027T3 (en) | Ripretinib for treating gastrointestinal stromal tumors | |
| IL287907A (en) | Cancer treatment methods | |
| IL276399A (en) | Combined treatment of stromal tumors in the digestive system | |
| IL263497B (en) | 1-tetrahydropyranylcarbonyl-3,2-dihydro-h1-indole compounds for cancer treatment | |
| IL272384B (en) | A process for the preparation of pyrrolidine compounds | |
| IL277861A (en) | Antibodies specific to AXL for cancer treatment | |
| KR102389409B9 (ko) | 벤팅 장치 | |
| IL267805B (en) | Compounds useful for the treatment of gastrointestinal disorders | |
| ES3066493T3 (en) | Compositions for treating tauopathy | |
| GB2581593B (en) | Apparatus for treating tumors by evanescent waves | |
| GB2586483B (en) | Unloading apparatus | |
| IL282958A (en) | Combination treatment for resistant hypertension | |
| GB201909468D0 (en) | Compounds for treating cancer | |
| IL292136A (en) | Vector for cancer treatment | |
| SG11202010528XA (en) | Combinations for treating cancer | |
| IL287593B (en) | Multivalent pd–l1 binding compounds for cancer therapy | |
| NO20190133A1 (en) | Fremgangsmåte for inspeksjon av rør | |
| GB202008537D0 (en) | Binding means for surface treatments | |
| IL290319A (en) | Compound for combined treatment | |
| GB201909466D0 (en) | Compounds for treating cancer | |
| SG10201910408QA (en) | Device for treating dysarthrosis | |
| GB201909188D0 (en) | Methhods for preparing compounds | |
| ZA202100843B (en) | Conjugate for treating cancer | |
| GB201912689D0 (en) | Improved call-blocking apparatus | |
| IL269414A (en) | Rapar for safetyin taneis |